Rebaudioside A (Reb A) is a steviol glycoside isolated from the leaves of the Stevia rebaudiana plant.

Acarbose sulfate (also known as BAY g 5421 sulfate; trade names: Glucobay; Prandase; Precose) is an anti-diabetic drug used to treat diabetes mellitus type 2 and, in some countries, prediabetes by combining with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes.

Kaempferol 3-O-gentiobioside is a novel and potent flavanoid.

Conduritol B epoxide (formerly known as CBE) is an irreversible/covalent inhibitor of non-mammalian and mammalian β-glucosidase (GCase).

LTI-291 is a CNS-penetrant and allosteric glucocerebrosidase (Gcase) activator that has the potential for treatment of Parkinson’s disease (PD).

CID-4694321 (also known as ML-266; ML266; CID-4694321) is a novel and potent activator of GCase (glucocerebrosidase) with the potential to be used for treating Gaucher disease.

Castanospermine, a novel indolizidine alkaloid first isolated from the seeds of Castanospermum australe, is a potent inhibitor of some glucosidase enzymes and has antiviral activity in vitro and in mouse models.

Licochalcone C is a naturally occuring chalcone compound and a potent inhibitor of lipopolysaccharide-interferon-γ inflammation.

Afegostat D-Tartrate (Isofagomine D-Tartrate, AT2101 D-Tartrate), designed as a pharmacological chaperone, was an experimental drug under investigation for the treatment of certain forms of Gaucher’s disease.

Acarbose (also known as BAY g 5421; trade names: Glucobay; Prandase; Precose) is an anti-diabetic drug used to treat diabetes mellitus type 2 and, in some countries, prediabetes by combining with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes.